Cited by 42

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice

Löffler, Tina, Flunkert, Stefanie, Havas, Daniel, Sántha, Miklós, Hutter-Paier, Birgit, Steyrer, Ernst, Windisch, Manfred·2013·Neurobiology of Aging

Abstract

During their lifetime, people are commonly exposed to several vascular risk factors that may affect brain ageing and cognitive function. In the last few years, increasing evidence suggests that pathological plasma lipid profiles contribute to the pathogenesis of late-onset Alzheimer's disease. Importantly, hypercholesterolemia, especially elevated low-density lipoprotein cholesterol values, that is, increased apolipoprotein B-100 (ApoB-100) levels, represents an independent risk factor. In this study, the effects of ApoB-100 overexpression, either alone or in combination with cerebral expression of human amyloid precursor protein (hAPP), on cognitive functions and brain pathology were assessed. Our results show that ApoB-100 overexpression induces memory decline and increases cerebral lipid peroxidation and amyloid beta levels compared to those in wild-type animals. Although double-transgenic ApoBxAPP animals did not develop more distinct behavioral deficits than single-transgenic hAPP littermates, hApoB-100 expression caused additional pathophysiological features, such as high LDL and low HDL-cholesterol levels, increased lipid peroxidation, and pronounced ApoB-100 accumulation in cerebral vessels. Thus, our results indicate that ApoBxAPP mice might better reflect the situation of elderly humans than hAPPsl overexpression alone.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2013.04.008

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Bereczki, 2008, Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice, J. Proteome Res., 7, 2246, 10.1021/pr7006329 · DOI · Paper page
  2. Bjelik, 2006, Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis, Neurochem. Int., 49, 393, 10.1016/j.neuint.2006.01.026 · DOI
  3. Bonomini, 2008, Atherosclerosis and oxidative stress, Histol. Histopathol., 23, 381
  4. Breslow, 1996, Mouse models of atherosclerosis, Science, 272, 685, 10.1126/science.272.5262.685 · DOI · Paper page
  5. Burns, 2002, Alzheimer's disease, Lancet, 360, 163, 10.1016/S0140-6736(02)09420-5 · DOI
  6. Callow, 1994, Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice, Proc. Natl. Acad. Sci. U.S.A., 91, 2130, 10.1073/pnas.91.6.2130 · DOI
  7. Callow, 1995, Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a), J. Clin. Invest., 96, 1639, 10.1172/JCI118203 · DOI
  8. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  9. Ferri, 2005, Global prevalence of dementia: a Delphi consensus study, Lancet, 366, 2112, 10.1016/S0140-6736(05)67889-0 · DOI
  10. Frisoni, 2010, The clinical use of structural MRI in Alzheimer disease, Nat. Rev. Neurol., 6, 67, 10.1038/nrneurol.2009.215 · DOI · Paper page
  11. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  12. Harman, 2006, Alzheimer's disease pathogenesis: role of aging, Ann. N. Y. Acad. Sci., 1067, 454, 10.1196/annals.1354.065 · DOI
  13. Havas, 2011, A longitudinal study of behavioral deficits in an AbetaPP transgenic mouse model of Alzheimer's disease, J. Alzheimers Dis., 25, 231, 10.3233/JAD-2011-101866 · DOI
  14. Humpel, 2011, Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?, Exp. Gerontol., 46, 225, 10.1016/j.exger.2010.11.032 · DOI
  15. Jarvik, 1995, Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study, Neurology, 45, 1092, 10.1212/WNL.45.6.1092 · DOI
  16. Kowalska, 2004, [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease], Neurologia i neurochirurgia polska, 38, 405
  17. Kuo, 1998, Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels, Biochem. Biophys. Res. Commun., 252, 711, 10.1006/bbrc.1998.9652 · DOI · Paper page
  18. Lenart, 2012, Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice, PLoS One, 7, e46007, 10.1371/journal.pone.0046007 · DOI
  19. Markesbery, 2005, Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment, Ann. Neurol., 58, 730, 10.1002/ana.20629 · DOI
  20. Martins, 2009, Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease, J. Neurochem., 111, 1275, 10.1111/j.1471-4159.2009.06408.x · DOI
  21. Miyakawa, 2010, Vascular pathology in Alzheimer's disease, Psychogeriatrics, 10, 39, 10.1111/j.1479-8301.2009.00294.x · DOI
  22. Morris, 1984, Developments of a water-maze procedure for studying spatial learning in the rat, J. Neurosci. Methods, 11, 47, 10.1016/0165-0270(84)90007-4 · DOI · Paper page
  23. Rockenstein, 2001, Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1–42), J. Neurosci. Res., 66, 573, 10.1002/jnr.1247 · DOI
  24. Skoog, 1999, Vascular factors and Alzheimer disease, Alzheimer Dis. Assoc. Disord., 13, S106, 10.1097/00002093-199912003-00016 · DOI
  25. Sparks, 2000, Link between heart disease, cholesterol, and Alzheimer's disease: a review, Microsc. Res. Techn., 50, 287, 10.1002/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L · DOI
  26. Sule, 2009, Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice, Life Sci., 84, 935, 10.1016/j.lfs.2009.04.011 · DOI
  27. Tanzi, 2001, New frontiers in Alzheimer's disease genetics, Neuron, 32, 181, 10.1016/S0896-6273(01)00476-7 · DOI
  28. Walsh, 2002, Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition, Biochem. Soc. Trans., 30, 552, 10.1042/bst0300552 · DOI
  29. Zou, 2002, A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage, J.Neurosci., 22, 4833, 10.1523/JNEUROSCI.22-12-04833.2002 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Löffler, T., Flunkert, S., Havas, D., Sántha, M., Hutter-Paier, B., Steyrer, E., & Windisch, M.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2013-10
Volume
34
Issue
10
Pages
2379-2388
ISSN
0197-4580
Cited by
42
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review